Advanced Biomed Inc.
Nasdaq · CIK 0001941029 · Fiscal year end 0630
Latest reported period: Latest published period
Net Income
$6.0M
Eps Basic
5.21
Eps Diluted
5.21
Recent financials
| Metric | Current | Prior | Change |
|---|---|---|---|
| Net Income | $6.0M | - | - |
| Eps Basic | 5.21 | - | - |
| Eps Diluted | 5.21 | - | - |
| Total Assets | $10.6M | - | - |
| Total Liabilities | $1.4M | - | - |
| Shareholders Equity | $9.2M | - | - |
| Operating Cash Flow | $-1.4M | - | - |
| Capital Expenditures | $15,941 | - | - |
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 10-Q | Advanced Biomed Inc. | 2026-05-15 | 0001213900-26-057226 |
| 10-Q | Advanced Biomed Inc. | 2026-02-13 | 0001213900-26-016458 |
| 10-Q | Advanced Biomed Inc. | 2025-11-19 | 0001213900-25-112602 |
| 10-K | Advanced Biomed Inc. | 2025-10-08 | 0001213900-25-097465 |